Skip to content

S. 95 · 118th Congress (2023–2025)

SAVE Moms and Babies Act of 2023

This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved.

Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner.

The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient.

The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)

Show official title

A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the approval of new abortion drugs, to prohibit investigational use exemptions for abortion drugs, and to impose additional regulatory requirements with respect to previously approved abortion drugs, and for other purposes.

Expired in Senate committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to committee

This bill’s path

This is S. 95’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Sen. Cindy Hyde-Smith (R-MS)
Cosponsors
32 cosponsors

25 original · 7 later

32 R

  1. Sen. Marsha Blackburn (R-TN)· Original · Jan 26, 2023
  2. Sen. John Barrasso (R-WY)· Original · Jan 26, 2023
  3. Sen. Mike Braun (R-IN)· Original · Jan 26, 2023
  4. Sen. Mike Crapo (R-ID)· Original · Jan 26, 2023
  5. Sen. John Cornyn (R-TX)· Original · Jan 26, 2023
  6. Sen. Tom Cotton (R-AR)· Original · Jan 26, 2023
  7. Sen. Kevin Cramer (R-ND)· Original · Jan 26, 2023
  8. Sen. Ted Cruz (R-TX)· Original · Jan 26, 2023
  9. Sen. Steve Daines (R-MT)· Original · Jan 26, 2023
  10. Sen. Deb Fischer (R-NE)· Original · Jan 26, 2023
  11. Sen. Lindsey Graham (R-SC)· Original · Jan 26, 2023
  12. Sen. Bill Hagerty (R-TN)· Original · Jan 26, 2023
  13. Sen. John Hoeven (R-ND)· Original · Jan 26, 2023
  14. Sen. Josh Hawley (R-MO)· Original · Jan 26, 2023
  15. Sen. Cynthia M. Lummis (R-WY)· Original · Jan 26, 2023
  16. Sen. James Lankford (R-OK)· Original · Jan 26, 2023
  17. Sen. Mike Lee (R-UT)· Original · Jan 26, 2023
  18. Sen. Roger Marshall (R-KS)· Original · Jan 26, 2023
  19. Sen. James E. Risch (R-ID)· Original · Jan 26, 2023
  20. Sen. Marco Rubio (R-FL)· Original · Jan 26, 2023
  21. Sen. Pete Ricketts (R-NE)· Original · Jan 26, 2023
  22. Sen. Rick Scott (R-FL)· Original · Jan 26, 2023
  23. Sen. John Thune (R-SD)· Original · Jan 26, 2023
  24. Sen. Roger F. Wicker (R-MS)· Original · Jan 26, 2023
  25. Sen. Todd Young (R-IN)· Original · Jan 26, 2023
  26. Sen. Mike Rounds (R-SD)· Later · Feb 7, 2023
  27. Sen. Ted Budd (R-NC)· Later · Mar 21, 2023
  28. Sen. John Boozman (R-AR)· Later · Sep 11, 2023
  29. Sen. Mitch McConnell (R-KY)· Later · Jan 8, 2024
  30. Sen. Jerry Moran (R-KS)· Later · Jan 8, 2024
  31. Sen. Markwayne Mullin (R-OK)· Later · Jan 30, 2024
  32. Sen. Katie Boyd Britt (R-AL)· Later · Dec 12, 2024
Policy area
Health
Subjects
  • Abortion
  • Drug safety, medical device, and laboratory regulation
  • Health information and medical records
  • Health personnel
  • Health technology, devices, supplies
  • Marketing and advertising
  • Prescription drugs

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest

    Referred to committee

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Sources
  3. Expired

    Introduced → Referred to Senate Health, Education, Labor, and Pensions → No further action before the 118th Congress ended.

Committees

  1. SenateHealth, Education, Labor, and PensionsReferred Jan 26, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Titles (3)
  1. SAVE Moms and Babies Act of 2023

    Display title, Short title · Introduced in Senate

  2. A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the approval of new abortion drugs, to prohibit investigational use exemptions for abortion drugs, and to impose additional regulatory requirements with respect to previously approved abortion drugs, and for other purposes.

    Official title · Introduced in Senate

  3. Support And Value Expectant Moms and Babies Act of 2023

    Short title · Introduced in Senate